Pegylated interferon-alpha2b and lamivudine in hepatitis B e antigen-positive chronic hepatitis B
- PMID: 16144900
- DOI: 10.7326/0003-4819-143-5-200509060-00018
Pegylated interferon-alpha2b and lamivudine in hepatitis B e antigen-positive chronic hepatitis B
Comment on
-
A randomized, controlled trial of combination therapy for chronic hepatitis B: comparing pegylated interferon-alpha2b and lamivudine with lamivudine alone.Ann Intern Med. 2005 Feb 15;142(4):240-50. doi: 10.7326/0003-4819-142-4-200502150-00006. Ann Intern Med. 2005. PMID: 15710957 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources